reserpine - CISMeF

Preferred Label : reserpine;

MeSH definition : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.;

CISMeF synonym : vangarde brand of reserpine; vitarine brand of reserpine;

MeSH hyponym : raupasil; rausedil; serpasil; V-Serp; raunervil; serpivite; Rausedyl; V Serp;

MeSH CAS label : Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-;

MeSH Related Number : 50-55-5 (Reserpine);

Registry Number MeSH : 50-55-5;

MeSH annotation : reserpine derivatives RESERPINE /analogs;

Wikipedia link : https://en.wikipedia.org/wiki/Reserpine;

Codes EINECS : 200-047-9;

Is substance : O;

UNII : 8B1QWR724A;

InChIKey : QEVHRUUCFGRFIF-MDEJGZGSSA-N;

Details

Origin ID

D012110;

UMLS CUI

C0035179;

ATC code(s)
- reserpine [ATC Code]
- reserpine and diuretics [ATC Code]
- reserpine and diuretics, combinations with other drugs [ATC Code]
- reserpine and diuretics, combinations with psycholeptics [ATC Code]
- reserpine, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Serpasil [ICHI extension code]
CISMeF manual mappings
- Adverse reaction caused by reserpine (disorder) [SNOMED CT concept]
- Reserpin (e) [ICD-11 Extension code]
- Reserpine poisoning (disorder) [SNOMED CT concept]
- reserpine [Substance BNPC]
Currated CISMeF NLP mapping
- Reserpine [ICD-11 Extension code]
- Reserpine [SMS substance]
- Reserpine [NCIt concept]
- Reserpine (substance) [SNOMED CT concept]
- Resperine [LOINC component]
- reserpine [SNOMED Notion]
Pharmacological action(s)
- adrenergic uptake inhibitors [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
- antipsychotic agents [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
- psychotropic drugs [MeSH Descriptor]
Record concept(s)
- V-Serp [MeSH concept]
- raunervil [MeSH concept]
- raupasil [MeSH concept]
- rausedil [MeSH concept]
- reserpine [MeSH concept]
- serpasil [MeSH concept]
- serpivite [MeSH concept]
Related MeSH Supplementary Concept(s)
- 16,18-reserpinediol [MeSH Supplementary Concept]
- CD 3400 [MeSH Supplementary Concept]
- althiazide, canrenoate potassium, rescinnamine drug combination [MeSH Supplementary Concept]
- bietaserpine [MeSH Supplementary Concept]
- bromoreserpine [MeSH Supplementary Concept]
- clopamide, dihydroergochristine, reserpine drug combination [MeSH Supplementary Concept]
- clopamide, dihydroergotoxine, reserpine drug combination [MeSH Supplementary Concept]
- deserpidine [MeSH Supplementary Concept]
- dibromoreserpine [MeSH Supplementary Concept]
- dihydralazine - hydrochlorothiazide - reserpine drug combination [MeSH Supplementary Concept]
- dihydralazine, reserpine drug combination [MeSH Supplementary Concept]
- enderpins [MeSH Supplementary Concept]
- hyparez [MeSH Supplementary Concept]
- inositol nicotinate, mefruside, reserpine drug combination [MeSH Supplementary Concept]
- mefrusid, methyldopa, reserpine drug combination [MeSH Supplementary Concept]
- meprocalm [MeSH Supplementary Concept]
- methyl reserpate [MeSH Supplementary Concept]
- nortensin [MeSH Supplementary Concept]
- regroton [MeSH Supplementary Concept]
- rescinamine [MeSH Supplementary Concept]
- rescinnamine [MeSH Supplementary Concept]
- reserpic acid [MeSH Supplementary Concept]
- reserpine methonitrate [MeSH Supplementary Concept]
- sinepres [MeSH Supplementary Concept]
- syrosingopine [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing reserpine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing reserpine (medicinal product) [SNOMED CT concept]
- Reserpine [NCIt concept]
- Reserpine (substance) [SNOMED CT concept]
- Resperine [LOINC component]
- reserpine [ATC Code]
- reserpine [Substance BNPC]
- reserpine [SNOMED Notion]
Validated automatic mappings to BTNT
- Serpasil [ICD-11 Extension code]
- reserpine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients